Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine
1 other identifier
observational
1,000
1 country
1
Brief Summary
This study aims to establish a large sample cohort of patients with primary sjogren's syndrome, collect multi-omics information of patients with primary sjogren's syndrome, and construct disease diagnosis model and disease prognosis prediction model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 4, 2024
CompletedFirst Submitted
Initial submission to the registry
July 12, 2024
CompletedFirst Posted
Study publicly available on registry
July 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJuly 30, 2024
July 1, 2024
1.5 years
July 12, 2024
July 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with system involvement
System involvement determined from clinical diagnosis
Baseline , 6 months follow-up
Secondary Outcomes (3)
Mortality
Baseline , 6 months follow-up
Number of participants with tumor
Baseline , 6 months follow-up
Number of participants with connective tissue disease
Baseline , 6 months follow-up
Study Arms (2)
Exposed group
Control group
Eligibility Criteria
Patients with primary Sjögren's syndrome
You may qualify if:
- Meets the 2002 AECG or 2016 ACR/EULAR classification criteria of primary Sjögren's syndrome.
You may not qualify if:
- Comorbid connective tissue disease other than the disease under research.
- Women who are pregnant or breastfeeding.
- Combined severe cardiovascular or cerebrovascular disease, hepatic or renal failure, or severe malignant tumors.
- Other conditions (e.g., cognitive impairment) that the investigators consider ineligible for enrollment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jiaqi Chen
Beijing, Beijing Municipality, 100029, China
Related Publications (1)
Lei C, Zhang X, Zhang Y, Fang Y, Chen J, Liu Z, Zhou X, Tang B, Liao J, Huang Z, Yang J, Wang Z, Liu T, Tao Q, Luo J. Sex differences in primary Sjogren's disease: prognostic impact on mortality and cancer. Biol Sex Differ. 2026 Jan 14. doi: 10.1186/s13293-026-00827-7. Online ahead of print.
PMID: 41530868DERIVED
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 30 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief physician
Study Record Dates
First Submitted
July 12, 2024
First Posted
July 30, 2024
Study Start
July 4, 2024
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
July 30, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share